Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.
2.

Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study.

Chen W, Delaloye S, Silverman DH, Geist C, Czernin J, Sayre J, Satyamurthy N, Pope W, Lai A, Phelps ME, Cloughesy T.

J Clin Oncol. 2007 Oct 20;25(30):4714-21.

3.

Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy.

Corroyer-Dulmont A, Pérès EA, Petit E, Guillamo JS, Varoqueaux N, Roussel S, Toutain J, Divoux D, MacKenzie ET, Delamare J, Ibazizène M, Lecocq M, Jacobs AH, Barré L, Bernaudin M, Valable S.

Neuro Oncol. 2013 Jan;15(1):41-56. doi: 10.1093/neuonc/nos260. Epub 2012 Oct 31.

4.

Complete remission after bevacizumab plus temozolomide in a patient with recurrent glioblastoma multiforme.

Kilickap S, Oztoprak I, Yucel B.

Acta Oncol. 2012 Apr;51(4):544-6. doi: 10.3109/0284186X.2011.644251. Epub 2011 Dec 27. No abstract available.

PMID:
22201408
5.

Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT.

Calabria F, Chiaravalloti A, Di Pietro B, Grasso C, Schillaci O.

Nucl Med Commun. 2012 Jun;33(6):563-70. doi: 10.1097/MNM.0b013e328351d566. Review.

PMID:
22395034
6.

Safety of 18F-DOPA injection for PET of carcinoid tumor.

Nataf V, Balard M, de Beco V, Kerrou K, Gutman F, Grahek D, Montravers F, Talbot JN.

J Nucl Med. 2006 Oct;47(10):1732; author reply 1732. No abstract available.

7.

Gangliogliomas: characterization by registered positron emission tomography-MR images.

Provenzale JM, Arata MA, Turkington TG, McLendon RE, Coleman RE.

AJR Am J Roentgenol. 1999 Apr;172(4):1103-7.

PMID:
10587156
8.

[18F]Fluoro-L-dopa PET/CT in congenital hyperinsulinism.

Subramaniam RM, Karantanis D, Peller PJ.

J Comput Assist Tomogr. 2007 Sep-Oct;31(5):770-2.

PMID:
17895790
9.

Infiltrative cerebellar ganglioglioma: conventional and advanced MRI, proton MR spectroscopic, and FDG PET findings in an 18-month-old child.

Löbel U, Ellison DW, Shulkin BL, Patay Z.

Clin Radiol. 2011 Feb;66(2):194-201. doi: 10.1016/j.crad.2010.10.005. Epub 2010 Nov 19. Review. No abstract available.

11.

Intracranial ganglioglioma: preoperative characteristics and oncologic outcome after surgery.

Im SH, Chung CK, Cho BK, Wang KC, Yu IK, Song IC, Cheon GJ, Lee DS, Kim NR, Chi JG.

J Neurooncol. 2002 Sep;59(2):173-83.

PMID:
12241112
12.

Treatment of children with glioblastoma with conformal radiation, temozolomide, and bevacizumab as adjuncts to surgical resection.

Friedman GK, Spiller SE, Harrison DK, Fiveash JB, Reddy AT.

J Pediatr Hematol Oncol. 2013 Apr;35(3):e123-6. doi: 10.1097/MPH.0b013e318282cd7f.

PMID:
23425999
13.
14.

[Resistance to first line chemotherapy treatment in a patient diagnosed of nodular lymphocyte-predominant Hodgkin's lymphoma identified by 18F-FDG PET/CT: diagnostic and therapeutic implications].

Banzo J, Ubieto MA, Giraldo P, Razola P, Prats E, Tardin L, Santapau A, Parra A, Rambalde EF, Velilla J.

Rev Esp Med Nucl Imagen Mol. 2012 Mar-Apr;31(2):89-92. doi: 10.1016/j.remn.2011.03.018. Epub 2011 May 26. Spanish.

15.

Vemurafenib in pediatric patients with BRAFV600E mutated high-grade gliomas.

Bautista F, Paci A, Minard-Colin V, Dufour C, Grill J, Lacroix L, Varlet P, Valteau-Couanet D, Geoerger B.

Pediatr Blood Cancer. 2014 Jun;61(6):1101-3. doi: 10.1002/pbc.24891. Epub 2013 Dec 3.

PMID:
24375920
16.

[Pseudoprogression or pseudoresponse: a challenge for the diagnostic imaging in Glioblastoma multiforme].

Payer F.

Wien Med Wochenschr. 2011 Jan;161(1-2):13-9. doi: 10.1007/s10354-010-0860-8. Review. German.

PMID:
21312094
17.

The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy.

Zani A, Nah SA, Ron O, Totonelli G, Ismail D, Smith VV, Ashworth M, Blankenstein O, Mohnike W, De Coppi P, Eaton S, Hussain K, Pierro A.

J Pediatr Surg. 2011 Jan;46(1):204-8. doi: 10.1016/j.jpedsurg.2010.09.093.

PMID:
21238668
18.

[Dual time point 18F-FDOPA PET as a tool for characterizing brain tumors].

González-Forero M, Prieto E, Domínguez I, Vigil C, Peñuelas I, Arbizu J.

Rev Esp Med Nucl. 2011 Mar-Apr;30(2):88-93. doi: 10.1016/j.remn.2010.11.007. Epub 2011 Feb 19. Spanish.

19.

Brainstem ganglioglioma successfully treated with vemurafenib.

Rush S, Foreman N, Liu A.

J Clin Oncol. 2013 Apr 1;31(10):e159-60. doi: 10.1200/JCO.2012.44.1568. Epub 2013 Jan 28. No abstract available.

20.

Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme.

Piroth MD, Pinkawa M, Holy R, Klotz J, Nussen S, Stoffels G, Coenen HH, Kaiser HJ, Langen KJ, Eble MJ.

Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):176-84. doi: 10.1016/j.ijrobp.2010.01.055. Epub 2010 Jun 18.

PMID:
20646863
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk